Pornumpa Bunjoungmanee

Pathum Thani, 12120, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Favipiravir treatment in Thai children with COVID-19: effectiveness, safety, and modeling drug exposure.

Favipiravir treatment in Thai children with COVID-19: effectiveness, safety, and modeling drug exposure.

Journal: Asian biomedicine : research, reviews and news

Published: June 17, 2026

Comparison of Immune Responses and Safety Profiles Following a Fourth Heterologous Dose (Second Booster) with mRNA-1273 in Individuals Previously Vaccinated with Two Doses of CoronaVac and a Booster Dose of Either AZD1222 or BNT162b2.

Comparison of Immune Responses and Safety Profiles Following a Fourth Heterologous Dose (Second Booster) with mRNA-1273 in Individuals Previously Vaccinated with Two Doses of CoronaVac and a Booster Dose of Either AZD1222 or BNT162b2.

Journal: Vaccines

Published: March 14, 2026

Prevalence and risk factors of Acinetobacter baumannii infection in Pediatric Intensive Care Unit at Thammasat University Hospital.

Prevalence and risk factors of Acinetobacter baumannii infection in Pediatric Intensive Care Unit at Thammasat University Hospital.

Journal: F1000Research

Published: May 16, 2025

Factors associated with severe respiratory syncytial virus infection among hospitalized children in Thammasat University Hospital.

Factors associated with severe respiratory syncytial virus infection among hospitalized children in Thammasat University Hospital.

Journal: F1000Research

Published: May 07, 2024

A reduced-dose recombinant pertussis vaccine booster in Thai adolescents: a phase 2/3, observer-blinded, randomised controlled, non-inferiority trial.

A reduced-dose recombinant pertussis vaccine booster in Thai adolescents: a phase 2/3, observer-blinded, randomised controlled, non-inferiority trial.

Journal: The Lancet. Child & adolescent health

Published: March 01, 2024

Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5-11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial.

Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5-11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial.

Journal: Vaccine

Published: May 11, 2023

Prevalence, risk factors, and vaccine effectiveness of COVID-19 infection in thai children, adolescents, and young adults in the omicron era.

Prevalence, risk factors, and vaccine effectiveness of COVID-19 infection in thai children, adolescents, and young adults in the omicron era.

Journal: Frontiers in pediatrics

Published: February 24, 2023

Real-life effectiveness of COVID-19 vaccine during the Omicron variant-dominant pandemic: how many booster doses do we need?

Real-life effectiveness of COVID-19 vaccine during the Omicron variant-dominant pandemic: how many booster doses do we need?

Journal: Emerging microbes & infections

Published: January 30, 2023

Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine.

Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine.

Journal: Vaccines

Published: January 03, 2023

Prevalence and associating factors of long COVID in pediatric patients during the Delta and the Omicron variants.

Prevalence and associating factors of long COVID in pediatric patients during the Delta and the Omicron variants.

Journal: Frontiers in pediatrics

Published: December 19, 2022

Low Measles Seropositivity Rate among Thai Adolescents in the Thai National Immunization Program.

Low Measles Seropositivity Rate among Thai Adolescents in the Thai National Immunization Program.

Journal: Vaccines

Published: June 30, 2022

Development and validation of the predictive score for pediatric COVID-19 pneumonia: A nationwide, multicenter study.

Development and validation of the predictive score for pediatric COVID-19 pneumonia: A nationwide, multicenter study.

Journal: PloS one

Published: May 06, 2022

Showing 1-12 of 19

Last Updated: 09/26/2026